T56.82
Toxic effect of gadolinium
Clinical Classification Guidelines
Excludes Type 1
- adverse effect of diagnostic agents (T50.8X5-)
Medical Intelligence & Overview
Gadolinium is a metallic element commonly used as a contrast agent in magnetic resonance imaging (MRI) procedures. While generally safe for most patients, exposure to gadolinium can sometimes lead to adverse effects, including toxicity. The ICD-10 code T56.82 specifically refers to cases where individuals experience a toxic effect caused by gadolinium. This condition requires careful medical management to address symptoms and prevent complications.
Causes & Symptoms
Clinical Causes: Use of gadolinium-based contrast agents during MRI scans Accumulation of gadolinium in the body, particularly in individuals with impaired kidney function Repeated exposure to gadolinium contrasts over a short period Blood-brain barrier disruptions that facilitate gadolinium's entry into tissues Inappropriate dosing or administration of gadolinium agents
Key Symptoms: Nausea and vomiting Headache and dizziness Skin reactions such as rash or itching Feeling of weakness or fatigue Joint or muscle pain In rare cases, neurological symptoms including cognitive disturbances Signs of kidney dysfunction in susceptible individuals Potential metallic taste or other sensory changes
Diagnostic & Treatment
Diagnosis Path: Diagnosing a toxic effect of gadolinium involves a comprehensive medical evaluation. Healthcare providers consider recent exposure to gadolinium-based contrast agents, clinical symptoms, and laboratory tests. Blood tests may assess kidney function, while imaging might be used to evaluate any tissue damage. In some cases, specialized tests detect gadolinium deposits within tissues. It is important to differentiate gadolinium toxicity from other conditions with similar symptoms.
Treatment Protocols: Supportive care such as hydration to facilitate gadolinium elimination Use of medications to alleviate specific symptoms like nausea or skin reactions Chelation therapy—although its efficacy in removing gadolinium is not well established, it may be considered in certain cases Close monitoring of renal function, especially in patients with pre-existing kidney issues Discontinuing further exposure to gadolinium contrast agents Regular follow-up to assess recovery and detect any delayed effects
Clinical Advice & FAQs
Billing Guidance
Is T56.82 a billable ICD-10 code?
Yes, T56.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T56.82?
Clinical documentation must specify the nature of Toxic effect of gadolinium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference